Thursday, March 9, 2023

Alembic Pharma gets USFDA nod to market generic antidepressant drug

Alembic Pharma gets USFDA nod to market generic antidepressant drug The company has received an approval from the US Food Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg, the drug firm said in a statement.

from Moneycontrol Business News https://ift.tt/2yPlHGY
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...